化疗方案比较翻译.docx

化疗方案比较翻译
泛瑞翻译
原文:
This author has personally seen responses binations of FolFOX (5-fluorouracil, leucovorin, and oxaliplatin), XELOX (capecitabine and oxaliplatin), binations with irinotecan and cetuximab. There has been some additional interesting hints of activity binations of capecitabine with gemcitabine, bination initially developed for the treatment of renal cell Responders with capecitabine and gemcitabine more typically occur inpatients who responded to the Gem-bination. Therefore, it is unlikely that bination would e initial resistance to 5-fluorouracil–based therapy. Given the similarity with colonic cancer, this author would also mend consideration of the addition of bevacizumab, and inhibitors of epidermal growth factor receptor (EGFR), including cetuximab, or panitumumab when available. This author also has seen cases in which patients may have benefited from long-term maintenance therapy with these antibodies. Additional responses have been reported with gemcitabine and cisplatin, S-1/cisplatin, and irinotecan. Un